BidaskClub upgraded shares of Sabra Health Care REIT (NASDAQ:SBRA) from a hold rating to a buy rating in a research note released on Thursday morning, BidAskClub reports.

Several other equities analysts have also issued reports on the company. ValuEngine lowered Zagg from a sell rating to a strong sell rating in a research note on Thursday, March 14th. Zacks Investment Research lowered Gold Resource from a hold rating to a sell rating in a research note on Friday, June 21st. Finally, TheStreet lowered Sabra Health Care REIT from a b- rating to a c+ rating in a research note on Monday, July 1st. Two research analysts have rated the stock with a sell rating, six have issued a hold rating and one has given a buy rating to the company. The company has a consensus rating of Hold and a consensus price target of $20.71.

Shares of SBRA traded down $0.10 during midday trading on Thursday, hitting $20.40. The company’s stock had a trading volume of 19,855 shares, compared to its average volume of 1,349,424. Sabra Health Care REIT has a one year low of $15.70 and a one year high of $23.83. The company’s fifty day moving average price is $19.67. The company has a debt-to-equity ratio of 1.06, a current ratio of 1.50 and a quick ratio of 1.50. The company has a market cap of $3.68 billion, a PE ratio of 8.95, a price-to-earnings-growth ratio of 11.51 and a beta of 0.89.

Sabra Health Care REIT (NASDAQ:SBRA) last issued its quarterly earnings results on Wednesday, May 8th. The real estate investment trust reported ($0.44) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.50 by ($0.94). Sabra Health Care REIT had a net margin of 23.38% and a return on equity of 4.25%. The business had revenue of $136.77 million during the quarter, compared to the consensus estimate of $144.87 million. As a group, equities analysts forecast that Sabra Health Care REIT will post 1.9 EPS for the current year.

Hedge funds have recently modified their holdings of the stock. Centaurus Financial Inc. bought a new stake in Sabra Health Care REIT during the 1st quarter worth $34,000. Wealthcare Advisory Partners LLC grew its position in Sabra Health Care REIT by 491.4% during the 1st quarter. Wealthcare Advisory Partners LLC now owns 2,419 shares of the real estate investment trust’s stock worth $47,000 after acquiring an additional 2,010 shares during the last quarter. Bronfman E.L. Rothschild L.P. grew its position in Sabra Health Care REIT by 913.7% during the 4th quarter. Bronfman E.L. Rothschild L.P. now owns 3,112 shares of the real estate investment trust’s stock worth $51,000 after acquiring an additional 2,805 shares during the last quarter. Bessemer Group Inc. bought a new stake in Sabra Health Care REIT during the 4th quarter worth $55,000. Finally, Fort L.P. bought a new stake in Sabra Health Care REIT during the 4th quarter worth $68,000. Institutional investors and hedge funds own 89.40% of the company’s stock.

About Sabra Health Care REIT

As of December 31, 2018, Sabra's investment portfolio included 470 real estate properties held for investment (consisting of (i) 335 Skilled Nursing/Transitional Care facilities, (ii) 90 Senior Housing communities (“Senior Housing – Leased”), (iii) 23 Senior Housing communities operated by third-party property managers pursuant to property management agreements (“Senior Housing – Managed”) and (iv) 22 Specialty Hospitals and Other facilities), one investment in a direct financing lease, 22 investments in loans receivable (consisting of (i) one mortgage loan, (ii) two construction loans, (iii) one mezzanine loan and (iv) 18 other loans), nine preferred equity investments and one investment in an unconsolidated joint venture that owns 172 Senior Housing – Managed communities.

Recommended Story: Commodities

Analyst Recommendations for Sabra Health Care REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.